Scalar field in the Bianchi I: Non commutative classical and Quantum Cosmology

Using the ADM formalism in the minisuperspace, we obtain the commutative and noncommutative exact classical solutions and exact wave function to the Wheeler-DeWitt equation with an arbitrary factor ordering, for the anisotropic Bianchi type I cosmological model, coupled to a scalar field, cosmological term and barotropic perfect fluid. We introduce noncommutative scale factors, considering that all minisuperspace variables $\rm q^i$ do not commute, so the symplectic structure was modified. In the classical regime, it is shown that the anisotropic parameter $\rm \beta_{\pm nc}$ and the field $\phi$, for some value in the $\lambda_{eff}$ cosmological term and noncommutative $\theta$ parameter, present a dynamical isotropization up to a critical cosmic time $t_{c}$; after this time, the effects of isotropization in the noncommutative minisuperspace seems to disappear. In the quantum regimen, the probability density presents a new structure that corresponds to the value of the noncommutativity parameter.Comment: 17 pages, 6 figures, Acepted in IJT

Noncommutativity, generalized uncertainty principle and FRW cosmology

We consider the effects of noncommutativity and the generalized uncertainty principle on the FRW cosmology with a scalar field. We show that, the cosmological constant problem and removability of initial curvature singularity find natural solutions in this scenarios.Comment: 8 pages, to appear in IJT

Hypothalamic S1p/s1pr1 axis controls energy homeostasis

Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-1-phosphate (S1P) that has a role in many physiological and pathophysiological processes. Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid, S1P, reduce food consumption and increase rat energy expenditure through persistent activation of STAT3 and the melanocortin system. Similarly, the selective disruption of hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We further show that STAT3 controls S1PR1 expression in neurons via a positive feedback mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3 signalling axis plays a critical role in the control of energy homeostasis in rats.Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-1-phosphate (S1P) that has a role in many physiological and pathophysiological processes. Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid, S1P, reduce food consumption and increase rat energy expenditure through persistent activation of STAT3 and the melanocortin system. Similarly, the selective disruption of hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We further show that STAT3 controls S1PR1 expression in neurons via a positive feedback mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3 signalling axis plays a critical role in the control of energy homeostasis in rats5485

Hypothalamic S1p/s1pr1 Axis Controls Energy Homeostasis

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Sphingosine 1-phosphate receptor 1 (S1PR1) is a G-protein-coupled receptor for sphingosine-1-phosphate (S1P) that has a role in many physiological and pathophysiological processes. Here we show that the S1P/S1PR1 signalling pathway in hypothalamic neurons regulates energy homeostasis in rodents. We demonstrate that S1PR1 protein is highly enriched in hypothalamic POMC neurons of rats. Intracerebroventricular injections of the bioactive lipid, S1P, reduce food consumption and increase rat energy expenditure through persistent activation of STAT3 and the melanocortin system. Similarly, the selective disruption of hypothalamic S1PR1 increases food intake and reduces the respiratory exchange ratio. We further show that STAT3 controls S1PR1 expression in neurons via a positive feedback mechanism. Interestingly, several models of obesity and cancer anorexia display an imbalance of hypothalamic S1P/S1PR1/STAT3 axis, whereas pharmacological intervention ameliorates these phenotypes. Taken together, our data demonstrate that the neuronal S1P/S1PR1/STAT3 signalling axis plays a critical role in the control of energy homeostasis in rats.5Capes-12900-13-3; CAPES; Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Schwartz, M.W., Woods, S.C., Porte, D., Jr., Seeley, R.J., Baskin, D.G., Central nervous system control of food intake (2000) Nature, 404, pp. 661-671Munzberg, H., Huo, L., Nillni, E.A., Hollenberg, A.N., Bjorbaek, C., Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin (2003) Endocrinology, 144, pp. 2121-2131Myers, M.G., Cowley, M.A., Munzberg, H., Mechanisms of leptin action and leptin resistance (2008) Annu. Rev. Physiol., 70, pp. 537-556Janoschek, R., Gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor (2006) Proc. Natl Acad. Sci. USA, 103, pp. 10707-10712Johnen, H., Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1 (2007) Nat. Med., 13, pp. 1333-1340Ropelle, E.R., IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition (2010) PLoS Biol., 8El-Haschimi, K., Pierroz, D.D., Hileman, S.M., Bjorbaek, C., Flier, J.S., Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity (2000) J. Clin. Invest., 105, pp. 1827-1832Ernst, M.B., Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity (2009) J. Neurosci., 29, pp. 11582-11593Gao, Q., Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals (2007) Nat. Med., 13, pp. 89-94Ghilardi, N., Defective STAT signaling by the leptin receptor in diabetic mice (1996) Proc. Natl Acad. Sci. USA, 93, pp. 6231-6235Frias, M.A., James, R.W., Gerber-Wicht, C., Lang, U., Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: Role of sphingosine-1-phosphate (2009) Cardiovasc. Res., 82, pp. 313-323Gurgui, M., Broere, R., Kalff, J.C., Van Echten-Deckert, G., Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells (2010) Cell Signal., 22, pp. 1727-1733Lee, H., STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors (2010) Nat. Med., 16, pp. 1421-1428Liang, J., Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer (2013) Cancer Cell, 23, pp. 107-120Spiegel, S., Milstien, S., The outs and the ins of sphingosine-1-phosphate in immunity (2011) Nat. Rev. Immunol., 11, pp. 403-415Spiegel, S., Milstien, S., Functions of the multifaceted family of sphingosine kinases and some close relatives (2007) J. Biol. Chem., 282, pp. 2125-2129Loh, K.C., Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway (2012) PLoS One, 7Lopez, M., Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin (2008) Cell. Metab., 7, pp. 389-399Oo, M.L., Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice (2011) J. Clin. Invest., 121, pp. 2290-2300Means, C.K., Brown, J.H., Sphingosine-1-phosphate receptor signalling in the heart (2009) Cardiovasc. Res., 82, pp. 193-200Schwartz, M.W., Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus (1997) Diabetes, 46, pp. 2119-2123Cowley, M.A., Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus (2001) Nature, 411, pp. 480-484Bates, S.H., STAT3 signalling is required for leptin regulation of energy balance but not reproduction (2003) Nature, 421, pp. 856-859Mynard, V., Guignat, L., Devin-Leclerc, J., Bertagna, X., Catelli, M.G., Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions (2002) Endocrinology, 143, pp. 3916-3924Bousquet, C., Zatelli, M.C., Melmed, S., Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immunoneuroendocrine interfacing (2000) J. Clin. Invest., 106, pp. 1417-1425Bousquet, C., Melmed, S., Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling (1999) J. Biol. Chem., 274, pp. 10723-10730Andreux, P.A., Systems genetics of metabolism: The use of the BXD murine reference panel for multiscalar integration of traits (2012) Cell, 150, pp. 1287-1299Guissouma, H., Froidevaux, M.S., Hassani, Z., Demeneix, B.A., In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription (2006) Neurosci. Lett., 406, pp. 240-243Froidevaux, M.S., The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo (2006) EMBO Rep., 7, pp. 1035-1039Nagahashi, M., Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis (2012) Cancer Res., 72, pp. 726-735Brinkmann, V., Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis (2010) Nat. Rev. Drug Discov., 9, pp. 883-897Graler, M.H., Goetzl, E.J., The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors (2004) FASEB J., 18, pp. 551-553Guo, H., An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway (2013) J. Neurosci., 33, pp. 6181-6190Ishii, I., Fukushima, N., Ye, X., Chun, J., Lysophospholipid receptors: Signaling and biology (2004) Annu. Rev. Biochem., 73, pp. 321-354Walter, D.H., Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor (2007) Arterioscler. Thromb. Vasc. Biol., 27, pp. 275-282Grossberg, A.J., Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130 (2010) Endocrinology, 151, pp. 606-616Febbraio, M.A., Gp130 receptor ligands as potential therapeutic targets for obesity (2007) J. Clin. Invest., 117, pp. 841-849Samad, F., Hester, K.D., Yang, G., Hannun, Y.A., Bielawski, J., Altered adipose and plasma sphingolipid metabolism in obesity: A potential mechanism for cardiovascular and metabolic risk (2006) Diabetes, 55, pp. 2579-2587Bence, K.K., Neuronal PTP1B regulates body weight, adiposity and leptin action (2006) Nat. Med., 12, pp. 917-924Chiarreotto-Ropelle, E.C., Acute exercise suppresses hypothalamic PTP1B protein level and improves insulin and leptin signaling in obese rats (2013) Am. J. Physiol. Endocrinol. Metab., 305, pp. E649-E659Picardi, P.K., Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats (2008) Endocrinology, 149, pp. 3870-3880Milanski, M., Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: Implications for the pathogenesis of obesity (2009) J. Neurosci., 29, pp. 359-370Purkayastha, S., Zhang, G., Cai, D., Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB (2011) Nat. Med., 17, pp. 883-887Zhang, X., Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity (2008) Cell, 135, pp. 61-73Laviano, A., Meguid, M.M., Rossi-Fanelli, F., Cancer anorexia: Clinical implications, pathogenesis, and therapeutic strategies (2003) Lancet Oncol., 4, pp. 686-694Tisdale, M.J., Biology of cachexia (1997) J. Natl Cancer Inst., 89, pp. 1763-1773Pchejetski, D., Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer (2010) Breast Cancer Res. Treat., 124, pp. 543-549Ponnusamy, S., Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis (2012) EMBO Mol. Med., 4, pp. 761-775Mellon, P.L., Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis (1990) Neuron, 5, pp. 1-1

COVAD survey 2 long-term outcomes: unmet need and protocol

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic. Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination. Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts. The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation. The e-survey has been extensively pilot-tested and validated with translations into multiple languages. Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups